FDA
approval
· 2022-04-05
FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
Summary
FDA approved a supplemental application for Macleods' irbesartan/hydrochlorothiazide combination tablet, expanding its labeling for the treatment of hypertensio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)